<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:chebi fb="1" ids="18421">superoxide</z:chebi> (<z:chebi fb="38" ids="18421,29356">O2-</z:chebi>)-releasing capacity in response to <z:chebi fb="0" ids="53490">N-formyl-methionyl-leucyl-phenylalanine</z:chebi> (<z:chebi fb="0" ids="53490">FMLP</z:chebi>) and the priming effects of recombinant human granulocyte colony-stimulating factor (rhG-CSF) and granulocyte-macrophage colony-stimulating factor (rhGM-CSF) on <z:chebi fb="0" ids="53490">FMLP</z:chebi>-induced <z:chebi fb="38" ids="18421,29356">O2-</z:chebi> release were investigated in neutrophils from 14 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>The O2(-)-releasing capacity in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> neutrophils varied from patient to patient </plain></SENT>
<SENT sid="2" pm="."><plain>As compared with <z:mpath ids='MPATH_458'>normal</z:mpath> neutrophils, the O2(-)-releasing capacity in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> neutrophils was increased in 9/14 patients, <z:mpath ids='MPATH_458'>normal</z:mpath> in three patients and decreased in two patients </plain></SENT>
<SENT sid="3" pm="."><plain>There was no close relationship between the O2(-)-releasing capacity and the peripheral blood neutrophil count or the plasma concentration of C-reactive protein </plain></SENT>
<SENT sid="4" pm="."><plain>The priming of neutrophils by rhG-CSF was not observed in five patients, whereas rhGM-CSF primed neutrophils from <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="5" pm="."><plain>The priming effect of rhGM-CSF was consistently greater than that of rhG-CSF in each patient </plain></SENT>
<SENT sid="6" pm="."><plain>The intravenous administration of rhG-CSF (300 micrograms/body) to two <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients showed an increase in the peripheral blood neutrophil count and enhancement of neutrophil <z:chebi fb="38" ids="18421,29356">O2-</z:chebi> release </plain></SENT>
<SENT sid="7" pm="."><plain>These findings demonstrate that the neutrophil O2(-)-releasing capacity in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> varies from patient to patient and is not always impaired, and that rhGM-CSF is able to prime neutrophils which never respond to rhG-CSF </plain></SENT>
</text></document>